NasdaqGS:PGNYHealthcare
Progyny Buyback Raises Questions On Capital Returns And Growth Plans
Progyny (NasdaqGS:PGNY) announced a US$200 million share repurchase program approved by its Board.
The authorization allows the company to buy back its common stock at its discretion over time.
This capital allocation decision signals management’s view of the business and potential impact on shareholder value.
Progyny focuses on fertility and family building benefits, a segment that sits at the intersection of healthcare, employer benefits, and demographic trends. As more employers look to...
